Maha M. Maher

Al Mansurah, DK, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled Study.

Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled Study.

Journal: Journal of clinical medicine

Published: March 22, 2025

The adjunctive role of metformin in patients with mild to moderate ulcerative colitis: a randomized controlled study.

The adjunctive role of metformin in patients with mild to moderate ulcerative colitis: a randomized controlled study.

Journal: Frontiers in pharmacology

Published: October 06, 2024

Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study.

Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study.

Journal: Frontiers in medicine

Published: September 02, 2024

Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study.

Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study.

Journal: Inflammopharmacology

Published: March 26, 2024

Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study.

Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study.

Journal: International immunopharmacology

Published: January 19, 2024

Inflammatory bowel disease evolution in the past two decades: a chronological multinational study.

Inflammatory bowel disease evolution in the past two decades: a chronological multinational study.

Journal: EClinicalMedicine

Published: October 18, 2023

Clinico-Epidemiological Characteristics of Patients With Inflammatory Bowel Disease in Egypt: A Nationwide Multicenter Study.

Clinico-Epidemiological Characteristics of Patients With Inflammatory Bowel Disease in Egypt: A Nationwide Multicenter Study.

Journal: Frontiers in medicine

Published: January 31, 2022

Inflammatory bowel disease: review and future view.

Inflammatory bowel disease: review and future view.

Journal: Frontiers in bioscience (Elite edition)

Published: December 29, 2011

Oxidative stress and inflammatory bowel disease.

Oxidative stress and inflammatory bowel disease.

Journal: Frontiers in bioscience (Elite edition)

Published: December 29, 2011

Study of respiratory disorders in endoscopically negative and positive gastroesophageal reflux disease.

Study of respiratory disorders in endoscopically negative and positive gastroesophageal reflux disease.

Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Published: March 27, 2010

Black esophagus: a case report.

Black esophagus: a case report.

Journal: Cases journal

Published: September 28, 2008

Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease.

Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease.

Journal: Digestive diseases and sciences

Published: March 23, 2008

Showing 1-12 of 13

Last Updated: 09/26/2026